o 129 has been researched along with trimethoprim, sulfamethoxazole drug combination in 3 studies
| Studies (o 129) | Trials (o 129) | Recent Studies (post-2010) (o 129) | Studies (trimethoprim, sulfamethoxazole drug combination) | Trials (trimethoprim, sulfamethoxazole drug combination) | Recent Studies (post-2010) (trimethoprim, sulfamethoxazole drug combination) |
|---|---|---|---|---|---|
| 30 | 0 | 2 | 7,527 | 875 | 2,260 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Que, TL; Wong, SS; Yam, WC; Yuen, KY | 1 |
| Albert, MJ; Falklind-Jerkérus, S; Weintraub, A | 1 |
| Batra, HV; Kingston, JJ; Kumar, S; Tuteja, U; Zachariah, K | 1 |
3 other study(ies) available for o 129 and trimethoprim, sulfamethoxazole drug combination
| Article | Year |
|---|---|
Vibrio cholerae O139 susceptible to vibriostatic agent 0/129 and co-trimoxazole.
Topics: Anti-Bacterial Agents; Drug Resistance, Microbial; Humans; Pteridines; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae | 1994 |
Lack of polymorphism in a Vibrio cholerae O139-specific DNA region encoding the somatic antigen in strains isolated during 1993-1998.
Topics: Anti-Bacterial Agents; Argentina; Asia; China; Cholera; DNA, Bacterial; Electrophoresis, Gel, Pulsed-Field; Hemolysis; Humans; O Antigens; Polymorphism, Genetic; Pteridines; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae O139 | 2003 |
Molecular characterization of Vibrio cholerae isolates from cholera outbreaks in North India.
Topics: Anti-Bacterial Agents; Cholera; Cloxacillin; Disease Outbreaks; DNA Fingerprinting; Endopeptidases; Fimbriae Proteins; Furazolidone; Genes, Bacterial; Humans; India; Microbial Sensitivity Tests; Nalidixic Acid; Polymyxin B; Pteridines; Streptomycin; Trimethoprim, Sulfamethoxazole Drug Combination; Vibrio cholerae O1 | 2009 |